A61H 2230/203
Used as a control parameter for the apparatus
Official title: used as a control parameter for the apparatus
A61H2230/203 (Used as a control parameter for the apparatus) appears on 15 US grants and 25 published applications in this corpus.
Search patents in A61H- Granted patents
- 15
- Published applications
- 25
- Assignees
- 13
- Inventors
- 31
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 2 | 8 |
| 2021 | 3 | 1 |
| 2022 | 2 | 4 |
| 2023 | 1 | 3 |
| 2024 | 2 | 1 |
| 2025 | 1 | 3 |
| 2026 | 3 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Diabetic foot analysis apparatus, and diabetic foot management system11 Aug 2026US 12,702,351 B2Hippo T&C, Inc.
- Dynamically controlled treatment protocols for autonomous treatment systems28 Jul 2026US 12,691,224 B2Nextern Innovation, LLC
- Portable automated life-saving system with dynamic adaptation19 May 2026US 12,629,092 B2Cpr Robotics Ltd.
- Using PH and SMO2 from a spectral sensor as an indication of subject down time8 Jul 2025US 12,350,012 B2ZOLL Medical Corporation
- Dynamically controlled treatment protocols for autonomous treatment systems30 Jul 2024US 12,048,832 B2Nextern Innovation, LLC
- Adaptive gastric vibrational therapy system with chewing detection and physiological monitoring6 Aug 2026US 2026/0224435 A1Appetec, Inc.
- Automatic blood sugar lowering exercise device19 Jun 2025US 2025/0195312 A1
- Dynamically Controlled Treatment Protocols for Autonomous Treatment Systems10 Apr 2025US 2025/0114522 A1Nextern Innovation, LLC
- Wearable device for providing exercise mode based on disease of user and operating method thereof9 Jan 2025US 2025/0010118 A1Samsung Electronics Co., Ltd.
- Diabetic foot analysis apparatus, and diabetic foot management system11 Apr 2024US 2024/0115191 A1Hippo T&C, Inc.
Most cited
By later US patents
- Dynamically controlled treatment protocols for autonomous treatment systems203US 10,792,422 B2White Bear Medical, LLC · 2020
- Systems and methods of wave generation for transcutaneous vibration18US 11,260,198 B2Apollo Neuroscience, Inc. · 2022
- Systems and methods of mitigating negative effects of therapies with transcutaneous vibration9US 10,974,020 B2Apollo Neuroscience, Inc. · 2021
- Systems and methods of facilitating sleep state entry with transcutaneous vibration4US 11,534,571 B2Apollo Neuroscience, Inc. · 2022
- Systems and methods of multi-segment transcutaneous vibratory output2US 11,872,351 B2Apollo Neuroscience, Inc. · 2024